Stereotactic body radiotherapy for central lung tumours: Author reply

被引：7

作者：

Adebahr, S. ^{[1
,2
]}

Collette, S. ^{[3
]}

Shash, E. ^{[3
]}

Lambrecht, M. ^{[4
]}

Le Pechoux, C. ^{[5
]}

Faivre-Finn, C. ^{[6
]}

De Ruysscher, D. ^{[7
]}

Peulen, H. ^{[8
]}

Belderbos, J. ^{[8
]}

Dziadziuszko, R. ^{[9
]}

Fink, C. ^{[10
]}

Guckenberger, M. ^{[11
]}

Hurkmans, C. ^{[4
]}

Nestle, U. ^{[1
,2
]}

机构：

[1] Univ Med Ctr Freiburg, Dept Radiat Oncol, Freiburg, Germany

[2] German Canc Consortium DKTK, Freiburg, Germany

[3] EORTC Headquarters, Brussels, Belgium

[4] Catharina Hosp, Dept Radiat Oncol, Eindhoven, Netherlands

[5] Univ Paris 11, Dept Radiat Oncoi, Villejuif, France

[6] Univ Manchester, Manchester Acad Hlth Sci Ctr, Christie NHS Fdn Trust, Inst Canc Sci, Manchester, Lancs, England

[7] KU Leuven Univ Leuven, Univ Hosp Leuven, Dept Radiat Oncol, Leuven, Belgium

[8] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands

[9] Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland

[10] Allgemeines Krankenhaus Celle, Dept Radiol, Celle, Germany

[11] Univ Zurich, Dept Radiat Oncol, Zurich, Switzerland

来源：

BRITISH JOURNAL OF RADIOLOGY | 2015年 / 88卷 / 1053期

关键词：

ABLATIVE RADIOTHERAPY;

D O I：

10.1259/bjr.20150532

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页数：2

共 50 条

[41] DOSIMETRIC PREDICTORS OF ESOPHAGEAL TOXICITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR CENTRAL LUNG TUMORS
Modh, Ankit
Williams, Eric
Rimner, Andreas
Foster, Amanda
Yorke, Ellen
Jackson, Andrew
Wu, Abraham J.
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S361 - S362
[42] Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy
Lodeweges, Joyce E.
van Rossum, Peter S. N.
Bartels, Marcia M. T. J.
van Lindert, Anne S. R.
Pomp, Jacqueline
Peters, Max
Verhoeff, Joost J. C.
ACTA ONCOLOGICA, 2021, 60 (08) : 1061 - 1068
[43] Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
Owen, Dawn
Sio, Terence T.
JOURNAL OF THORACIC DISEASE, 2020, 12 (11) : 7024 - 7031
[44] Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy
Lodeweges, J.
van Rossum, P.
Bartels, M.
van Lindert, A.
Pomp, J.
Peters, M.
Verhoeff, J.
RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S972 - S973
[45] Dosimetric predictors, of esophageal toxicity after stereotactic body radiotherapy for central lung tumors
Wu, Abraham J.
Williams, Eric
Modh, Ankit
Foster, Amanda
Yorke, Ellen
Rimner, Andreas
Jackson, Andrew
RADIOTHERAPY AND ONCOLOGY, 2014, 112 (02) : 267 - 271
[46] Stereotactic body radiotherapy (SBRT) for lung cancer:: Clinical experience for medically inoperable lung tumours with excellent local control
Larrea, L.
Lopez, E.
Bea, J.
Banos, M. C.
Garcia, M. A.
Munoz, J.
Albert, A.
EJC SUPPLEMENTS, 2007, 5 (04): : 380 - 380
[47] Optimizing dose prescription in stereotactic body radiotherapy for lung tumours using Monte Carlo dose calculation
Widder, Joachim
Hollander, Miranda
Ubbels, Jan F.
Bolt, Rene A.
Langendijk, Johannes A.
RADIOTHERAPY AND ONCOLOGY, 2010, 94 (01) : 42 - 46
[48] Understanding Responses to Stereotactic Body Radiotherapy and Pembrolizumab Reply
Luke, Jason J.
Chmura, Steven J.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (25) : 2662 - +
[49] Stereotactic Body Radiotherapy (SBRT) for Central Lung Tumors: The Experience of Florence University-Careggi Hospital Radiotherapy
Scotti, Vieri
Di Cataldo, Vanessa
Simontacchi, Gabriele
Bruni, Alessio
Turkaj, Ana
Carta, Giulio Alberto
Perna, Marco
Becherine, Carlotta
Comin, Camilla
Ferrari, Katia
Agresti, Benedetta
Cardillo, Carla De Luca
Masi, Laura
Doro, Raffaela
Livi, Lorenzo
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1042 - S1042
[50] Stereotactic radiotherapy for pelvic tumours
Mazeron, R.
Fumagalli, I.
CANCER RADIOTHERAPIE, 2014, 18 (04): : 325 - 331

← 1 2 3 4 5 →